|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ding L, Getz G, Wheeler DA, Mardis ER,
McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan
MB, et al: Somatic mutations affect key pathways in lung
adenocarcinoma. Nature. 455:1069–1075. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mulshine JL and D'Amico TA: Issues with
implementing a high-quality lung cancer screening program. CA
Cancer J Clin. 64:352–363. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bowry SK, Kircelli F, Himmele R and
Nigwekar SU: Blood-incompatibility in haemodialysis: Alleviating
inflammation and effects of coagulation. Clin Kidney J. 14 (Suppl
4):i59–i71. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ain D, Shaikh T, Manimala S and
Ghebrehiwet B: The role of complement in the tumor
microenvironment. Fac Rev. 10(80)2021.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Afshar-Kharghan V: The role of the
complement system in cancer. J Clin Invest. 127:780–789.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Sacks SH and Zhou W: The role of
complement in the early immune response to transplantation. Nat Rev
Immunol. 12:431–442. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Kochanek DM, Ghouse SM, Karbowniczek MM
and Markiewski MM: Complementing cancer metastasis. Front Immunol.
9(1629)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zirakzadeh AA, Sherif A, Rosenblatt R,
Bergman EA, Winerdal M, Yang D, Cederwall J, Jakobsson V,
Hyllienmark M, Winqvist O and Marits P: Tumour-associated B cells
in urothelial urinary bladder cancer. Scand J Immunol.
91(e12830)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cedzynski M and Swierzko AS: Components of
the lectin pathway of complement in solid tumour cancers. Cancers
(Basel). 14(1543)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kemper C and Köhl J: Back to the
future-non-canonical functions of complement. Semin Immunol.
37:1–3. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kolev M, Le Friec G and Kemper C:
Complement-tapping into new sites and effector systems. Nat Rev
Immunol. 14:811–820. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Niculescu F, Rus HG, Retegan M and Vlaicu
R: Persistent complement activation on tumor cells in breast
cancer. Am J Pathol. 140:1039–1043. 1992.PubMed/NCBI
|
|
15
|
Razvi Y, Chan S, Zhang L, Tsao M, Barnes
E, Danjoux C, Sousa P, Zaki P, McKenzie E, DeAngelis C and Chow E:
A review of the rapid response radiotherapy program in patients
with advanced cancer referred for palliative radiotherapy over two
decades. Support Care Cancer. 27:2131–2134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Barakat A, Mittal A, Ricketts D and Rogers
BA: Understanding survival analysis: Actuarial life tables and the
Kaplan-Meier plot. Br J Hosp Med (Lond). 80:642–646.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schlosser P, Knaus J, Schmutz M, Dohner K,
Plass C, Bullinger L, Claus R, Binder H, Lubbert M and Schumacher
M: Netboost: Boosting-supported network analysis improves
high-dimensional omics prediction in acute myeloid leukemia and
huntington's disease. IEEE/ACM Trans Comput Biol Bioinform.
18:2635–2648. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kleinendorst RWD, Barzaghi G, Smith ML,
Zaugg JB and Krebs AR: Genome-wide quantification of transcription
factor binding at single-DNA-molecule resolution using
methyl-transferase footprinting. Nat Protoc. 16:5673–5706.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
LaFreniere LS, Newman MG and Graham JW:
Parental support and monitoring influences on adolescent alcohol
use: A peer selection mediation model. Ment Health Addict Res.
6(10)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Min SH and Zhou J: Smplot: An R package
for easy and elegant data visualization. Front Genet.
12(802894)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang H, Wu J, Xie K, Fang T, Chen C, Xie
H, Zhou L and Zheng S: Precise engineering of prodrug cocktails
into single polymeric nanoparticles for combination cancer therapy:
Extended and sequentially controllable drug release. ACS Appl Mater
Interfaces. 9:10567–10576. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Niu C, Wu D, Li AJ, Qin KH, Hu DA, Wang
EJ, Tucker AB, He F, Huang L, Wang H, et al: Identification of a
prognostic signature based on copy number variations (CNVs) and
CNV-modulated gene expression in acute myeloid leukemia. Am J
Transl Res. 13:13683–13696. 2021.PubMed/NCBI
|
|
23
|
Kandathil A, Kay FU, Butt YM, Wachsmann JW
and Subramaniam RM: Role of FDG PET/CT in the eighth edition of TNM
staging of non-small cell lung cancer. Radiographics. 38:2134–2149.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pisani G and Baron B: Nuclear paraspeckles
function in mediating gene regulatory and apoptotic pathways.
Noncoding RNA Res. 4:128–134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
de Matos AL, Franco LS and McFadden G:
Oncolytic viruses and the immune system: The dynamic duo. Mol Ther
Methods Clin Dev. 17:349–358. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Arthur CM, Chonat S, Fasano R, Yee MEM,
Josephson CD, Roback JD and Stowell SR: Examining the role of
complement in predicting, preventing, and treating hemolytic
transfusion reactions. Transfus Med Rev. 33:217–224.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Noh EM, Kim JM, Lee HY, Song HK, Joung SO,
Yang HJ, Kim MJ, Kim KS and Lee YR: Immuno-enhancement effects of
platycodon grandiflorum extracts in splenocytes and a
cyclophosphamide-induced immunosuppressed rat model. BMC Complement
Altern Med. 19(322)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cserhalmi M, Papp A, Brandus B, Uzonyi B
and Józsi M: Regulation of regulators: Role of the complement
factor H-related proteins. Semin Immunol. 45(101341)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Osther K, Fornvik K, Liljedahl E, Salford
LG and Redebrandt HN: Upregulation of C1-inhibitor in pancreatic
cancer. Oncotarget. 10:5703–5712. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ramos AA, Castro-Carvalho B, Prata-Sena M,
Malhão F, Buttachon S, Dethoup T, Kijjoa A and Rocha E: Can
marine-derived fungus Neosartorya siamensis KUFA 0017
extract and its secondary metabolites enhance antitumor activity of
doxorubicin? An in vitro survey unveils interactions against lung
cancer cells. Environ Toxicol. 35:507–517. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Boonruang S, Prakobsri K, Pouyfung P,
Prasopthum A, Rongnoparut P and Sarapusit S: Structure-activity
relationship and in vitro inhibition of human cytochrome CYP2A6 and
CYP2A13 by flavonoids. Xenobiotica. 50:630–639. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cedeno DL, Tilley DM, Vetri F, Platt DC
and Vallejo R: Proteomic and phosphoproteomic changes of
MAPK-related inflammatory response in an animal model of
neuropathic pain by differential target multiplexed SCS and
low-rate SCS. J Pain Res. 15:895–907. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yokoyama S, Hamada T, Higashi M, Matsuo K,
Maemura K, Kurahara H, Horinouchi M, Hiraki T, Sugimoto T, Akahane
T, et al: Predicted prognosis of pancreatic cancer patients by
machine learning. Clin Cancer Res. 26:2411–2421. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Muntel J, Gandhi T, Verbeke L, Bernhardt
OM, Treiber T, Bruderer R and Reiter L: Surpassing 10 000
identified and quantified proteins in a single run by optimizing
current LC-MS instrumentation and data analysis strategy. Mol
Omics. 15:348–360. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li J, Cao Z, Mi L, Xu Z and Wu X:
Complement sC5b-9 and CH50 increase the risk of cancer-related
mortality in patients with non-small cell lung cancer. J Cancer.
11:7157–7165. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Oner F, Savaş I and Numanoğlu N:
Immunoglobulins and complement components in patients with lung
cancer. Tuberk Toraks. 52:19–23. 2004.PubMed/NCBI
|
|
37
|
Ruggenenti P, Di Marco F, Cortinovis M,
Lorini L, Sala S, Novelli L, Raimondi F, Gastoldi S, Galbusera M,
Donadelli R, et al: Eculizumab in patients with severe coronavirus
disease 2019 (COVID-19) requiring continuous positive airway
pressure ventilator support: Retrospective cohort study. PLoS One.
16(e0261113)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Keshari RS, Silasi R, Popescu NI, Regmi G,
Chaaban H, Lambris JD, Lupu C, Mollnes TE and Lupu F: CD14
inhibition improves survival and attenuates thrombo-inflammation
and cardiopulmonary dysfunction in a baboon model of Escherichia
coli sepsis. J Thromb Haemost. 19:429–443. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mezo B, Horvath O, Sinkovits G, Veszeli N,
Kriván G and Prohászka Z: Validation of early increase in
complement activation marker sC5b-9 as a predictive biomarker for
the development of thrombotic microangiopathy after stem cell
transplantation. Front Med (Lausanne). 7(569291)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Palikhe A, Sinisalo J, Seppanen M, Haario
H, Meri S, Valtonen V, Nieminen MS and Lokki ML: Serum complement
C3/C4 ratio, a novel marker for recurrent cardiovascular events. Am
J Cardiol. 99:890–895. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Iltumur K, Karabulut A, Toprak G and
Toprak N: Complement activation in acute coronary syndromes. APMIS.
113:167–174. 2005.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Balachandran VP, Gonen M, Smith JJ and
DeMatteo RP: Nomograms in oncology: More than meets the eye. Lancet
Oncol. 16:e173–e180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yang Y, Qu A, Zhao R, Hua M, Zhang X, Dong
Z, Zheng G, Pan H, Wang H, Yang X and Zhang Y: Genome-wide
identification of a novel miRNA-based signature to predict
recurrence in patients with gastric cancer. Mol Oncol.
12:2072–2084. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kawai K, Ishihara S, Yamaguchi H, Sunami
E, Kitayama J, Miyata H and Watanabe T: Nomogram prediction of
metachronous colorectal neoplasms in patients with colorectal
cancer. Ann Surg. 261:926–932. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lv Y, Duanmu J, Fu X, Li T and Jiang Q:
Identifying a new microRNA signature as a prognostic biomarker in
colon cancer. PLoS One. 15(e0228575)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang L, Chen J, Wang L, Chen L, Du Z, Zhu
L, Cui M, Zhang M and Song L: Linc-PINT acted as a tumor suppressor
by sponging miR-543 and miR-576-5p in esophageal cancer. J Cell
Biochem. 120:19345–19357. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yang Y, Qu A, Wu Q, Zhang X, Wang L, Li C,
Dong Z, Du L and Wang C: Prognostic value of a hypoxia-related
microRNA signature in patients with colorectal cancer. Aging
(Albany NY). 12:35–52. 2020.PubMed/NCBI View Article : Google Scholar
|
